Kirin Holdings EBITDA 2010-2024 | KNBWY
Kirin Holdings ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Kirin Holdings Annual EBITDA
(Millions of US $) |
| 2023 |
$1,686 |
| 2022 |
$1,555 |
| 2021 |
$1,358 |
| 2020 |
$1,739 |
| 2019 |
$1,550 |
| 2018 |
$2,423 |
| 2017 |
$2,495 |
| 2016 |
$2,223 |
| 2015 |
$2,038 |
| 2014 |
$2,028 |
| 2013 |
$2,513 |
| 2012 |
$2,962 |
| 2011 |
$3,674 |
| 2010 |
$3,208 |
| 2009 |
$2,815 |
Kirin Holdings Quarterly EBITDA
(Millions of US $) |
| 2024-03-31 |
$350 |
| 2023-03-31 |
$234 |
| 2022-03-31 |
$355 |
| 2021-03-31 |
$446 |
| 2020-03-31 |
$240 |
| 2019-03-31 |
$-271 |
| 2018-03-31 |
$458 |
| 2017-03-31 |
$324 |
| 2016-12-31 |
$4,874 |
| 2016-09-30 |
$5,225 |
| 2016-06-30 |
$5,085 |
| 2016-03-31 |
$207 |
| 2015-12-31 |
$4,698 |
| 2015-09-30 |
$4,598 |
| 2015-06-30 |
$4,551 |
| 2015-03-31 |
$221 |
| 2014-12-31 |
$5,171 |
| 2014-09-30 |
$5,100 |
| 2014-06-30 |
$5,138 |
| 2014-03-31 |
$318 |
| 2013-12-31 |
$5,642 |
| 2013-09-30 |
$6,192 |
| 2013-06-30 |
$5,871 |
| 2013-03-31 |
$-169 |
| 2012-12-31 |
$6,021 |
| 2012-09-30 |
$7,056 |
| 2012-06-30 |
$6,926 |
| 2012-03-31 |
$254 |
| 2011-12-31 |
$6,729 |
| 2011-09-30 |
$7,014 |
| 2011-06-30 |
$6,521 |
| 2011-03-31 |
$1,028 |
| 2010-12-31 |
$7,049 |
| 2010-09-30 |
$7,331 |
| 2010-06-30 |
$6,582 |
| 2010-03-31 |
$587 |
| 2009-12-31 |
$7,186 |
| 2009-09-30 |
$-10,760 |
| 2009-06-30 |
$6,001 |
| 2009-03-31 |
$416 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Alcoholic Beverages |
$0.000B |
$15.222B |
|
Kirin Holdings Company, Limited is engaged in the manufacture and sale of alcohol beverages and soft drinks. The Company has four segments: Alcohol Beverage segment, Beverage and Food segment, Pharmaceutical and Biochemicals segment and Others segment. It offers beer, wine, ready-to-drink products, spirits, coffee, black tea, Japanese tea, mineral water, juices, dairy products and beverages, seasonings, soft drinks, freeze-dried soups, milk, and cheese. Kirin also engages in the research, development, manufacture and sale of various pharmaceutical products, manufacture and sale of diagnostic reagents, production and maintenance of genetically modified cattle and the research and development of human polyclonal antibody platform technology. Kirin Holdings Company, Limited, formerly known as Kirin Brewery Company, is headquartered in Tokyo, Japan.
|
